Search research articles
Contact Us
Filters
Showing results (71-80 of 129) with videos related to
Page
of 13
Sort By:
Plos One
|
December 24, 2011
Adaption of seasonal H1N1 influenza virus in mice
Lili Xu, Linlin Bao, Fengdi Li, et al.
Nature Communications
|
March 31, 2015
Human monoclonal antibodies targeting the haemagglutinin glycoprotein can neutralize H7N9 influenza virus
Zhe Chen, Jianmin Wang, Linlin Bao, et al.
The Journal of Infectious Diseases
|
May 5, 2017
Human Neutralizing Monoclonal Antibody Inhibition of Middle East Respiratory Syndrome Coronavirus Replication in the Common Marmoset
Zhe Chen, Linlin Bao, Cong Chen, et al.
Animal Models and Experimental Medicine
|
May 21, 2025
Comparison of the pathogenicity of multiple SARS-CoV-2 variants in mouse models
Qi Lv, Ming Liu, Feifei Qi, et al.
Virus Research
|
April 13, 2010
Challenge and polymorphism analysis of the novel A (H1N1) influenza virus to normal animals
Linlin Bao, Lili Xu, Lingjun Zhan, et al.
Cell Research
|
June 7, 2022
Selection and structural bases of potent broadly neutralizing antibodies from 3-dose vaccinees that are highly effective against diverse SARS-CoV-2 variants, including Omicron sublineages
Lei Wang, Wangjun Fu, Linlin Bao, et al.
The Journal of General Virology
|
October 3, 2014
Combinations of oseltamivir and fibrates prolong the mean survival time of mice infected with the lethal H7N9 influenza virus
Lili Xu, Linlin Bao, Fengdi Li, et al.
Plos One
|
June 24, 2011
Genomic polymorphism of the pandemic A (H1N1) influenza viruses correlates with viral replication, virulence, and pathogenicity in vitro and in vivo
Lili Xu, Linlin Bao, Jianfang Zhou, et al.
Plos One
|
July 7, 2020
Correction: Genomic Polymorphism of the Pandemic A (H1N1) Influenza Viruses Correlates with Viral Replication, Virulence, and Pathogenicity In Vitro and In Vivo
Lili Xu, Linlin Bao, Jianfang Zhou, et al.
International Immunopharmacology
|
November 23, 2025
Jubang Huashi Yin and its active component cynaroside alleviate excessive inflammation in COVID-19 by inhibiting IKKβ activity
Wenting Huang, Liansheng Qiao, Linlin Bao, et al.
Page
of 13
Search research articles
Search
Showing results (71-80 of 129) with videos related to
Sort By:
Page
of 13
Plos One
|
December 24, 2011
Adaption of seasonal H1N1 influenza virus in mice
Lili Xu, Linlin Bao, Fengdi Li, et al.
Nature Communications
|
March 31, 2015
Human monoclonal antibodies targeting the haemagglutinin glycoprotein can neutralize H7N9 influenza virus
Zhe Chen, Jianmin Wang, Linlin Bao, et al.
The Journal of Infectious Diseases
|
May 5, 2017
Human Neutralizing Monoclonal Antibody Inhibition of Middle East Respiratory Syndrome Coronavirus Replication in the Common Marmoset
Zhe Chen, Linlin Bao, Cong Chen, et al.
Animal Models and Experimental Medicine
|
May 21, 2025
Comparison of the pathogenicity of multiple SARS-CoV-2 variants in mouse models
Qi Lv, Ming Liu, Feifei Qi, et al.
Virus Research
|
April 13, 2010
Challenge and polymorphism analysis of the novel A (H1N1) influenza virus to normal animals
Linlin Bao, Lili Xu, Lingjun Zhan, et al.
Cell Research
|
June 7, 2022
Selection and structural bases of potent broadly neutralizing antibodies from 3-dose vaccinees that are highly effective against diverse SARS-CoV-2 variants, including Omicron sublineages
Lei Wang, Wangjun Fu, Linlin Bao, et al.
The Journal of General Virology
|
October 3, 2014
Combinations of oseltamivir and fibrates prolong the mean survival time of mice infected with the lethal H7N9 influenza virus
Lili Xu, Linlin Bao, Fengdi Li, et al.
Plos One
|
June 24, 2011
Genomic polymorphism of the pandemic A (H1N1) influenza viruses correlates with viral replication, virulence, and pathogenicity in vitro and in vivo
Lili Xu, Linlin Bao, Jianfang Zhou, et al.
Plos One
|
July 7, 2020
Correction: Genomic Polymorphism of the Pandemic A (H1N1) Influenza Viruses Correlates with Viral Replication, Virulence, and Pathogenicity In Vitro and In Vivo
Lili Xu, Linlin Bao, Jianfang Zhou, et al.
International Immunopharmacology
|
November 23, 2025
Jubang Huashi Yin and its active component cynaroside alleviate excessive inflammation in COVID-19 by inhibiting IKKβ activity
Wenting Huang, Liansheng Qiao, Linlin Bao, et al.
Page
of 13